Snowden Capital Advisors LLC Buys New Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Snowden Capital Advisors LLC purchased a new position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 8,089 shares of the company's stock, valued at approximately $560,000.

Several other institutional investors have also bought and sold shares of HSIC. Barclays PLC lifted its holdings in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company's stock valued at $20,882,000 after purchasing an additional 18,458 shares during the last quarter. Merit Financial Group LLC raised its position in shares of Henry Schein by 15.8% in the fourth quarter. Merit Financial Group LLC now owns 23,137 shares of the company's stock valued at $1,601,000 after purchasing an additional 3,156 shares during the period. Fifth Third Bancorp lifted its stake in shares of Henry Schein by 11.0% during the 4th quarter. Fifth Third Bancorp now owns 3,366 shares of the company's stock valued at $233,000 after buying an additional 333 shares in the last quarter. Olstein Capital Management L.P. lifted its stake in shares of Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after buying an additional 16,000 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. bought a new position in Henry Schein in the 4th quarter worth approximately $763,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on HSIC. Wells Fargo & Company lowered their target price on shares of Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 6th. Barrington Research decreased their price objective on Henry Schein from $90.00 to $86.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 6th. Wall Street Zen downgraded Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. UBS Group decreased their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 26th. Finally, Piper Sandler lowered their price target on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating on the stock in a report on Wednesday, April 30th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Henry Schein has a consensus rating of "Moderate Buy" and an average price target of $79.30.

Insider Buying and Selling

In other Henry Schein news, Director Philip A. Laskawy sold 2,604 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total value of $287,161.40. Following the transaction, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This trade represents a 6.05% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.08% of the stock is owned by company insiders.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded up $0.32 during midday trading on Monday, hitting $71.65. 1,534,999 shares of the company's stock were exchanged, compared to its average volume of 1,662,145. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market cap of $8.72 billion, a price-to-earnings ratio of 29.49, a PEG ratio of 2.13 and a beta of 0.87. The business's fifty day moving average price is $67.46 and its two-hundred day moving average price is $71.53.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. The business had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's quarterly revenue was down .1% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.10 EPS. As a group, research analysts forecast that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.